Oral GLP-1 Providers Compared: Who Offers Oral Formats and How They Stack Up

The number-one barrier to GLP-1 adoption has always been the same: needles. Even with auto-injectors and ultra-thin needles, a significant portion of potential patients delay or avoid treatment because of injection anxiety. That's why the oral GLP-1 market is one of the fastest-growing segments in telehealth — and why understanding which providers offer what is increasingly important.

The Oral GLP-1 Landscape in July 2026

Three categories of oral GLP-1 options exist right now:

1. FDA-approved brand-name oral semaglutide. Oral Wegovy (semaglutide 25mg for weight management) launched in January 2026 at $149/month through NovoCare. This is a genuine game-changer — it's an FDA-approved, brand-name GLP-1 in pill form at a price point lower than many compounded injectable programs. Rybelsus (oral semaglutide for type 2 diabetes) has been available longer but at a lower dose and different indication.

2. Compounded oral semaglutide formulations. Several compounding pharmacies have developed oral semaglutide in sublingual troche (lozenge) and other non-injection formats. These are not FDA-approved but offer an alternative delivery method for patients who want compounded pricing without needles.

3. Pipeline oral GLP-1s (not yet available). Eli Lilly's orforglipron and Novo Nordisk's amycretin are both in late-stage clinical trials. If approved, they'll add more oral options to the market, likely in 2027.

Providers With Oral Options

For Brand-Name Oral Wegovy: Sesame Care

Sesame Care offers affordable consultations ($49/visit) with licensed providers who can prescribe FDA-approved brand-name oral Wegovy. You'll fill the prescription through a pharmacy or manufacturer program. At $149/month through NovoCare, the brand-name oral Wegovy pill is now competitively priced with many compounded injectable options — a significant market shift.

For Compounded Oral Formats: Strut Health

Strut Health is one of the few compounding-focused providers that offers oral semaglutide in sublingual lozenge form alongside traditional injectable options. This gives patients the flexibility to choose their preferred delivery method. The lozenge format absorbs through the mucous membranes under the tongue, bypassing some of the absorption challenges of oral tablets.

For Flexible Format Selection: Other Top Providers

Several leading compounded providers primarily offer injectable semaglutide and tirzepatide, which remains the gold standard for bioavailability and efficacy. While injectable, modern auto-injectors have made the process much simpler than it was even a year ago.

Oral vs Injectable: What the Data Shows

Here's what you need to know about the efficacy comparison:

Absorption differences. Injectable semaglutide has near-100% bioavailability — almost all of the medication reaches your bloodstream. Oral semaglutide has significantly lower bioavailability (roughly 1–2% for tablet forms), which is why the oral dose (25mg for Wegovy pill) is much higher than the injectable dose (2.4mg). The clinical trials accounted for this by calibrating the oral dose to achieve comparable blood levels.

Weight loss results. The OASIS-1 clinical trial showed that oral semaglutide 50mg produced weight loss comparable to injectable semaglutide 2.4mg (approximately 15–17% body weight reduction). The approved 25mg oral dose showed slightly lower but still clinically meaningful weight loss.

Timing requirements. Oral semaglutide must be taken on an empty stomach with a small amount of water, followed by a 30-minute fasting period. This timing requirement is strict — food, other medications, and even too much water can significantly reduce absorption. Injectable semaglutide has no such restrictions.

Side effect profile. Gastrointestinal side effects (nausea, diarrhea, constipation) occur with both formats. Some studies suggest oral formulations may cause slightly more GI discomfort initially, though the difference typically diminishes after the first few weeks.

Who Should Choose Oral?

Oral GLP-1s make the most sense for patients who:

• Have genuine needle anxiety that would prevent them from starting or continuing treatment
• Travel frequently and prefer not to carry injectable supplies
• Want an FDA-approved brand-name option at the new $149/month price point
• Are comfortable with the daily timing requirements (empty stomach, 30-minute fast)

Injectable GLP-1s may still be preferable for patients who want the highest bioavailability, prefer a weekly schedule over daily dosing, or want access to tirzepatide (which does not yet have an approved oral formulation).

Oral GLP-1 Provider Comparison